Clinical factors associated with delayed diagnosis in hospitalized community-acquired pneumonia (CAP). Impact on the outcome Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010
Clinical stability and switch therapy in hospitalised patients with community-acquired pneumonia: are we there yet? Source: Eur Respir J 2013; 41: 5-6 Year: 2013
Changes in empirical initial antibiotic therapy in community-acquired pneumonia: assessment of clinical failure versus discordant therapy Source: Eur Respir J 2006; 28: Suppl. 50, 736s Year: 2006
The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012
Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Impact of reducing antibiotic treatment on inflammation among patients with community-acquired pneumonia. Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019
Timing of antibiotic administration and outcomes for patients with community-acquired pneumonia (CAP). NAC-CV Study Source: Eur Respir J 2006; 28: Suppl. 50, 349s Year: 2006
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005
I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas! Year: 2009
Early outcomes in CAP: clinical stability, clinical failure and nonresolving pneumonia Source: Eur Respir Monogr 2014; 63: 205-218 Year: 2014
Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia Source: Annual Congress 2004 - SARS and other lower respiratory tract infections Year: 2004
Impact of age and comorbidity on presentation, aetiology and outcome in patients with community-acquired pneumonia Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012
Defining community-acquired pneumonia severity on presentation to hospital: a derivation study Source: Eur Respir J 2004; 24: Suppl. 48, 186s Year: 2004
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia Source: Eur Respir J 2007; 30: 517-524 Year: 2007
Prolonged hospitalization in community-acquired pneumonia. Influence of clinical factors and hospital characteristics Source: Eur Respir J 2003; 22: Suppl. 45, 544s Year: 2003
Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis Source: Eur Respir J 2008; 31: 1068-1076 Year: 2008
Clinical pneumonia: how do I make a specific diagnosis? Source: Virtual Congress 2021 – The "State of the Art" in the diagnosis of bacterial, mycobacterial, and fungal pneumonias Year: 2021
Japanese guidelines for the management of community-acquired pneumonia: differential diagnosis of atypical pneumonia and bacterial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 374s Year: 2006
Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment Source: Eur Respir J 2008; 32: 139-146 Year: 2008
Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis Source: Eur Respir J 2011; 37: 858-864 Year: 2011